Published in Br J Surg on December 01, 1988
Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology (2008) 3.95
Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Ann Surg (1993) 2.26
Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg (1999) 2.23
Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol (2009) 2.17
Migration of biliary plastic stents: experience of a tertiary center. Surg Endosc (2008) 1.81
Percutaneous drainage and stenting for palliation of malignant bile duct obstruction. Eur Radiol (2007) 1.80
Surgical management of 552 carcinomas of the extrahepatic bile ducts (gallbladder and periampullary tumors excluded). Results of the French Surgical Association Survey. Ann Surg (1991) 1.75
Optimum palliation of inoperable hilar cholangiocarcinoma: comparative assessment of the efficacy of plastic and self-expanding metal stents. Dig Dis Sci (2011) 1.71
Pancreatic cancer cell DNA content correlates with long-term survival after pancreatoduodenectomy. Ann Surg (1991) 1.55
Current management of pancreatic carcinoma. Ann Surg (1995) 1.54
The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy. Ann Surg (1996) 1.50
Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas. Gut (2005) 1.46
Towards safer endoscopic retrograde cholangiopancreatography. Gut (1993) 1.30
Safety and efficacy of radiofrequency ablation in the management of unresectable bile duct and pancreatic cancer: a novel palliation technique. J Oncol (2013) 1.29
Plastic biliary stent occlusion: factors involved and possible preventive approaches. Clin Med Res (2007) 1.26
Laparoscopic staging and subsequent palliation in patients with peripancreatic carcinoma. Ann Surg (2003) 1.20
Palliative treatment of malignant obstruction of gastric outlet using an endoscopically placed enteral Wallstent. Dig Dis Sci (2001) 1.15
Guidelines for the application of surgery and endoprostheses in the palliation of obstructive jaundice in advanced cancer of the pancreas. Ann Surg (1994) 1.12
Nonoperative imaging techniques in suspected biliary tract obstruction. HPB (Oxford) (2006) 1.12
Diagnostic difficulties in patients with a pancreatic mass. BMJ (1991) 1.08
Tannenbaum and metal stents in the palliative treatment of malignant distal bile duct obstruction: a comparative study of patency and cost effectiveness. Surg Endosc (2006) 1.05
Predictive factors for survival of patients with inoperable malignant distal biliary strictures: a practical management guideline. Gut (1998) 1.03
A meta-analysis of randomized trials: immediate stent placement vs. surgical bypass in the palliative management of malignant biliary obstruction. J Pain Symptom Manage (2013) 0.98
Should endoscopic stenting be the initial treatment of malignant biliary obstruction? Ann R Coll Surg Engl (1992) 0.97
Advances in the Genetic Screening, Work-up, and Treatment of Pancreatic Cancer. Curr Treat Options Gastroenterol (2004) 0.96
Drainage and bypass procedures for palliation of malignant diseases of the upper gastrointestinal tract. Clin Oncol (R Coll Radiol) (2010) 0.94
Surgical bypass vs. endoscopic stenting for pancreatic ductal adenocarcinoma. HPB (Oxford) (2009) 0.90
Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: trends and lessons learned from a large, single institution experience. J Gastrointest Surg (2011) 0.89
Advances in endoscopic retrograde cholangiopancreatography for the treatment of cholangiocarcinoma. World J Gastrointest Endosc (2015) 0.89
Palliation of malignant obstructive jaundice. Dig Dis Sci (2008) 0.88
Surgical palliation in patients with pancreatic cancer. Langenbecks Arch Surg (2006) 0.87
Cohort study of surgical bypass to the gallbladder or bile duct for the palliation of jaundice due to pancreatic cancer. Ann Surg (2003) 0.86
Pancreatic carcinoma: palliative surgical and endoscopic treatment. HPB (Oxford) (2006) 0.86
Predictors of early stent occlusion among plastic biliary stents. Dig Dis Sci (2012) 0.85
Metallic biliary stents for malignant obstructive jaundice:a review. World J Gastroenterol (2000) 0.85
Endoscopic inside stent placement is suitable as a bridging treatment for preoperative biliary tract cancer. BMC Gastroenterol (2015) 0.84
Cystic duct patency in malignant obstructive jaundice. An ERCP-based study relevant to the role of laparoscopic cholecystojejunostomy. Ann Surg (1995) 0.83
Laparoscopic biliary and gastric bypass: a useful adjunct in the treatment of carcinoma of the pancreas. Gut (1995) 0.83
Comparison of outcomes among secondary covered metallic, uncovered metallic, and plastic biliary stents in treating occluded primary metallic stents in malignant distal biliary obstruction. Surg Endosc (2010) 0.83
Mechanisms of Biliary Plastic Stent Occlusion and Efforts at Prevention. Clin Endosc (2016) 0.83
Palliative laparoscopic hepatico- and gastrojejunostomy for advanced pancreatic cancer. JSLS (2002) 0.83
Nitinol biliary stent versus surgery for palliation of distal malignant biliary obstruction. Surg Endosc (2010) 0.83
Evidence-based decompression in malignant biliary obstruction. Korean J Radiol (2012) 0.83
Findings at endoscopic retrograde cholangiopancreatography after endoscopic treatment of postcholecystectomy bile leaks. Surg Endosc (2009) 0.83
Efficacy and safety of covered self-expandable metal stents for management of distal malignant biliary obstruction due to lymph node metastases. Surg Endosc (2011) 0.83
Multicenter Randomized Trial of 10-French versus 11.5-French Plastic Stents for Malignant Biliary Obstruction. Diagn Ther Endosc (2013) 0.82
Robot-assisted laparoscopic choledochojejunostomy. Surg Endosc (2003) 0.82
ERCP and stent therapy for progressive jaundice in hepatocellular carcinoma: which patients benefit, which patients don't? Dig Dis Sci (1999) 0.81
Endoscopic palliation and survival in malignant biliary obstruction. Dig Dis Sci (2001) 0.81
Operative procedures for unresectable pancreatic cancer: does operative bypass decrease requirements for postoperative procedures and in-hospital days? HPB (Oxford) (2012) 0.81
Endoscopic and surgical palliation of gastrointestinal tumors. Support Care Cancer (2004) 0.80
Surgical palliation of unresectable pancreatic head cancer in elderly patients. World J Gastroenterol (2009) 0.80
Percutaneous intraductal radiofrequency ablation in the management of unresectable Bismuth types III and IV hilar cholangiocarcinoma. Oncotarget (2016) 0.80
Double bypass for inoperable pancreatic malignancy at laparotomy: postoperative complications and long-term outcome. Ann R Coll Surg Engl (2012) 0.80
Endoscopic management of occluded metal biliary stents: metal versus 10F plastic stents. World J Gastroenterol (2010) 0.80
Endoscopic biliary stenting in a district general hospital. Gut (1995) 0.80
Stent versus surgery. HPB (Oxford) (2007) 0.79
Bridge to surgery using partially covered self-expandable metal stents (PCMS) in malignant biliary stricture: an acceptable paradigm? Surg Endosc (2010) 0.79
Guidelines for palliative surgery of cholangiocarcinoma. HPB (Oxford) (2008) 0.78
Outcomes and risk factors for cancer patients undergoing endoscopic intervention of malignant biliary obstruction. BMC Gastroenterol (2015) 0.78
Controversial issues in the management of pancreatic cancer: Part one. A debate held at St Mary's Hospital, London on 18 November 1993. Ann R Coll Surg Engl (1995) 0.78
Impact of Radiofrequency Ablation on Malignant Biliary Strictures: Results of a Collaborative Registry. Dig Dis Sci (2015) 0.78
A comparative study on the efficacy of covered metal stent and plastic stent in unresectable malignant biliary obstruction. Clin Endosc (2012) 0.77
Impact of anticancer treatment on recurrent obstruction in covered metallic stents for malignant biliary obstruction. J Gastroenterol (2013) 0.76
Management of upper gastrointestinal cancers. Qual Health Care (2001) 0.76
Palliative Endoscopic Treatment Options in Malignancies of the Biliopancreatic System. Viszeralmedizin (2014) 0.75
Surgery offers the best palliation for carcinoma of the pancreas. Ann R Coll Surg Engl (1991) 0.75
Self-expanding metal stents for duodenal obstruction in advanced pancreatic adenocarcinoma. HPB (Oxford) (2008) 0.75
Endoscopic radiofrequency ablation combined with fully covered self-expandable metal stent for inoperable periampullary carcinoma in a liver transplant patient: A case report. Medicine (Baltimore) (2017) 0.75
Partially Covered Metal Stents May Not Prolong Stent Patency Compared to Uncovered Stents in Unresectable Malignant Distal Biliary Obstruction. Gut Liver (2017) 0.75
Biliary bypass and palliation for pancreatic cancer. J R Soc Med (1990) 0.75
Laparoscopic choledochojejunostomy via PTFE-covered stent successfully achieves internal drainage of common bile duct obstruction. HPB (Oxford) (2005) 0.75
Surgical palliation for pancreatic carcinoma. Postgrad Med J (1991) 0.75
Percutaneous intraductal radiofrequency ablation for treatment of biliary stent occlusion: A preliminary result. World J Gastroenterol (2017) 0.75
Efficacy and safety of limited endoscopic sphincterotomy before self-expandable metal stent insertion for malignant biliary obstruction. World J Gastroenterol (2017) 0.75
Endoscopic radiofrequency ablation for malignant biliary strictures. Exp Ther Med (2016) 0.75
Cholangiocarcinoma and malignant bile duct obstruction: A review of last decades advances in therapeutic endoscopy. World J Gastrointest Endosc (2015) 0.75
Palliative interventional and surgical therapy for unresectable pancreatic cancer. Cancers (Basel) (2011) 0.75
A meta-analysis and systematic review: Success of endoscopic ultrasound guided biliary stenting in patients with inoperable malignant biliary strictures and a failed ERCP. Medicine (Baltimore) (2017) 0.75
Are self-expandable metal stents superior to plastic stents in palliating malignant distal biliary strictures? A meta-analysis and systematic review. Med J Armed Forces India (2016) 0.75
Resolution of recent evolutionary divergence among Escherichia coli from related lineages: the application of pulsed field electrophoresis to molecular epidemiology. J Infect Dis (1990) 8.33
Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. Biochemistry (1991) 5.90
Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ (1995) 4.50
Identification of vancomycin resistance protein VanA as a D-alanine:D-alanine ligase of altered substrate specificity. Biochemistry (1991) 3.76
Sequence of the vanC gene of Enterococcus gallinarum BM4174 encoding a D-alanine:D-alanine ligase-related protein necessary for vancomycin resistance. Gene (1992) 3.68
The VANA glycopeptide resistance protein is related to D-alanyl-D-alanine ligase cell wall biosynthesis enzymes. Mol Gen Genet (1990) 3.66
Estrogens and endometrial cancer in a retirement community. N Engl J Med (1976) 3.64
Evidence for natural gene transfer from gram-positive cocci to Escherichia coli. J Bacteriol (1988) 3.43
Glycopeptide resistance mediated by enterococcal transposon Tn1546 requires production of VanX for hydrolysis of D-alanyl-D-alanine. Mol Microbiol (1994) 2.90
Distribution of erythromycin esterase and rRNA methylase genes in members of the family Enterobacteriaceae highly resistant to erythromycin. Antimicrob Agents Chemother (1987) 2.80
The fat embolism syndrome: with special reference to the importance of hypoxia in the syndrome. Ann R Coll Surg Engl (1970) 2.65
A case-control study of menopausal estrogen therapy and breast cancer. JAMA (1980) 2.15
Menopausal estrogen therapy and hip fractures. Ann Intern Med (1981) 2.13
Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene. Blood (1996) 1.99
'Quick and clean': authoritative health technology assessment for local health care contracting. Health Trends (1995) 1.89
Resistance of enterococci to aminoglycosides and glycopeptides. Clin Infect Dis (1992) 1.89
Junior doctors on the warpath. BMJ (1992) 1.85
Contribution of two different mechanisms to erythromycin resistance in Escherichia coli. Antimicrob Agents Chemother (1986) 1.82
Carcinoma of the proximal bile ducts. Surg Gynecol Obstet (1973) 1.81
Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faecium. Antimicrob Agents Chemother (1991) 1.81
Analysis of the nucleotide sequence of the ereB gene encoding the erythromycin esterase type II. Nucleic Acids Res (1986) 1.79
A groove in the lateral wall of the orbit. J Anat (1973) 1.77
Menopausal oestrogen therapy and protection from death from ischaemic heart disease. Lancet (1981) 1.77
Characterization of vanY, a DD-carboxypeptidase from vancomycin-resistant Enterococcus faecium BM4147. Antimicrob Agents Chemother (1992) 1.73
Novel mechanism of beta-lactam resistance due to bypass of DD-transpeptidation in Enterococcus faecium. J Biol Chem (2000) 1.62
Mutations leading to increased levels of resistance to glycopeptide antibiotics in VanB-type enterococci. Mol Microbiol (1997) 1.60
Preliminary report on isolation of mycobacteria from patients with Crohn's disease. Dig Dis Sci (1989) 1.60
Metastatic carcinoma causing haematemesis. Br Med J (1975) 1.58
The case against showing patients their records. Br Med J (Clin Res Ed) (1986) 1.56
Reserpine and breast cancer in a retirement community. N Engl J Med (1975) 1.55
Incidence of inguinal hernia recurrence. Effect of time off work after repair. Ann R Coll Surg Engl (1975) 1.54
Comparison of twice-daily ranitidine with standard cimetidine treatment of duodenal ulcer. Gut (1981) 1.50
Comparison between low and high pressure suction drainage following axillary clearance. Eur J Surg Oncol (2000) 1.43
Guidelines for the management of oesophageal and gastric cancer. Gut (2002) 1.42
Multiplicity of macrolide-lincosamide-streptogramin antibiotic resistance determinants. J Antimicrob Chemother (1985) 1.42
Characterization and modelling of VanT: a novel, membrane-bound, serine racemase from vancomycin-resistant Enterococcus gallinarum BM4174. Mol Microbiol (1999) 1.42
Specificity of induction of glycopeptide resistance genes in Enterococcus faecalis. Antimicrob Agents Chemother (1996) 1.41
Measuring tracheal airway pressures during transtracheal jet ventilation: an observational study. Anaesthesia (2004) 1.40
Mortality study of 18 000 patients treated with omeprazole. Gut (2003) 1.39
Genetic epidemiology of early onset breast cancer. J Med Genet (1994) 1.37
Structural and functional analysis of the plasminogen activator inhibitor-1 binding motif in the somatomedin B domain of vitronectin. J Biol Chem (1996) 1.31
Alterations in hepatic bile composition after cholecystectomy. Gastroenterology (1972) 1.30
Fine needle aspiration cytology of breast masses: an evaluation of its accuracy and reasons for diagnostic failure. Ann R Coll Surg Engl (1987) 1.28
Role of penicillin-binding protein 5 in expression of ampicillin resistance and peptidoglycan structure in Enterococcus faecium. Antimicrob Agents Chemother (2001) 1.28
Inactivation of the Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells. Blood (1997) 1.27
Selection of glycopeptide-resistant mutants of VanB-type Enterococcus faecalis BM4281 in vitro and in experimental endocarditis. J Infect Dis (1997) 1.22
Mycobacteria in Crohn's disease: DNA probes identify the wood pigeon strain of Mycobacterium avium and Mycobacterium paratuberculosis from human tissue. J Clin Microbiol (1992) 1.21
Meta-analysis of neuropsychological symptoms of adolescents and adults with PKU. Neuropsychol Rev (2007) 1.21
Increased prevalence of epilepsy in coeliac disease. Br Med J (1978) 1.20
Alzheimer's disease in antacid users. Lancet (1989) 1.17
Two-step acquisition of resistance to the teicoplanin-gentamicin combination by VanB-type Enterococcus faecalis in vitro and in experimental endocarditis. Antimicrob Agents Chemother (1999) 1.14
Mechanisms of inactivation and resistance of spores to chemical biocides. Soc Appl Bacteriol Symp Ser (1994) 1.11
Influence of trauma system implementation on process of care delivered to seriously injured patients in rural trauma centers. Surgery (2001) 1.09
Management of screen-detected breast cancer: audit of the first 100 cases in the Southampton and Salisbury breast screening programme. Ann R Coll Surg Engl (1993) 1.05
Single-cell analysis of glycopeptide resistance gene expression in teicoplanin-resistant mutants of a VanB-type Enterococcus faecalis. Mol Microbiol (1999) 1.04
Overproduction of 3'-aminoglycoside phosphotransferase type I confers resistance to tobramycin in Escherichia coli. Antimicrob Agents Chemother (1993) 1.02
Recent changes in the surgical management of T1/2 breast cancer in England. Eur J Cancer (1992) 1.01
Extrahepatic biliary obstruction by a common bile duct inflammatory polyp in association with a gallstone, and treatment by endoscopic sphincterotomy. Endoscopy (1986) 0.99
Origin, evolution and dissemination of antibiotic resistance genes. Microbiol Sci (1987) 0.99
Fighting resistant tuberculosis with old compounds: the carbapenem paradigm. Clin Microbiol Infect (2011) 0.99
The value of serum lipase estimations in the fat embolism syndrome. Surgery (1969) 0.99
Regulation of icosahedral virion capsid size by the in vivo activity of a cloned gene product. Proc Natl Acad Sci U S A (1990) 0.97
Empirical electro-optical and x-ray performance evaluation of CMOS active pixels sensor for low dose, high resolution x-ray medical imaging. Med Phys (2007) 0.96
Treatment of acute anterior dislocation of the shoulder. Br J Clin Pract (1973) 0.96
Characterization of CrgA, a new partner of the Mycobacterium tuberculosis peptidoglycan polymerization complexes. J Bacteriol (2011) 0.95
A neuropsychological profile of off-diet adults with phenylketonuria. J Clin Exp Neuropsychol (2007) 0.93
Optimizing the cell efficacy of synthetic ribozymes. Site selection and chemical modifications of ribozymes targeting the proto-oncogene c-myb. J Biol Chem (1996) 0.92
Latent severe anoxia associated with the fat embolism syndrome. A case report. Br J Anaesth (1968) 0.91
Portal hypertension presenting with haemoperitoneum. Br Med J (1970) 0.91
Identification of the UDP-MurNAc-pentapeptide:L-alanine ligase for synthesis of branched peptidoglycan precursors in Enterococcus faecalis. J Bacteriol (2001) 0.90
Mortality among seriously injured patients treated in remote rural trauma centers before and after implementation of a statewide trauma system. Med Care (2001) 0.90
Bactericidal activity of gentamicin against Enterococcus faecalis in vitro and in vivo. Antimicrob Agents Chemother (2000) 0.90
In vitro activity of cefoxitin and imipenem against Mycobacterium abscessus complex. Clin Microbiol Infect (2013) 0.90
Torsade de pointes ventricular tachycardia associated with astemizole overdose. Br J Clin Pract (1988) 0.89
Hyperinfection with Strongyloides stercoralis in Great Britain. Br J Surg (1974) 0.89
Effective treatment of diabetic diarrhoea with somatostatin analogue, octreotide. Gut (1992) 0.88
An anomalous origin of the middle meningeal artery. J Neurol Neurosurg Psychiatry (1973) 0.88
Smoking, gastric secretion, and inhibition by H2 receptor antagonists. Lancet (1985) 0.86
Metaraminol for priapism. Lancet (1984) 0.86
Ulcerative colitis and carcinoma of the proximal bile ducts. Gut (1973) 0.86
Knotted drainage tube: practical points in its prevention. Ann R Coll Surg Engl (1984) 0.85
The PAI-1/vitronectin interaction: two cats in a bag? Thromb Haemost (1995) 0.85
Metabolic changes following the intravenous infusion of Corynebacterium parvum in man. Cancer (1979) 0.85
The absorption of carbenoxolone administered orally as a positioned-release capsule. Gut (1970) 0.85
The physics of Cerenkov light production during proton therapy. Phys Med Biol (2014) 0.84
Interaction of Bacillus subtilis spores with sodium hypochlorite, sodium dichloroisocyanurate and chloramine-T. J Appl Bacteriol (1992) 0.84
An evaluation of the repeatability and reproducibility of a surface test for the activity of disinfectants. J Appl Bacteriol (1994) 0.84
Restoration of liver function in Gunn rats without immunosuppression using transplanted microencapsulated hepatocytes. Hepatology (1990) 0.84
Event-related potentials elicited during a visual Go-Nogo task in adults with phenylketonuria. Clin Neurophysiol (2006) 0.83
Cryopreserved microencapsulated hepatocytes--transplantation studies in Gunn rats. Transplantation (1993) 0.83
Myelodysplastic syndrome and trisomy 14q. Cancer Genet Cytogenet (1992) 0.82
Galactose and hepatic metabolism in malnutrition and sepsis in man. Clin Sci Mol Med (1978) 0.81
Backbone and side-chain 1H, 15N and 13C assignment of apo- and imipenem-acylated L,D-transpeptidase from Bacillus subtilis. Biomol NMR Assign (2012) 0.81
Oral fingolimod for the treatment of patients with relapsing forms of multiple sclerosis. Int J Clin Pract (2011) 0.80
Improved function of microencapsulated hepatocytes in a hybrid bioartificial liver support system. Artif Organs (1992) 0.80
Immune responses of healthy humans 83-104 years of age. J Natl Cancer Inst (1983) 0.80
Treatment of cytophagic panniculitis with cyclosporin A. Am J Med (1992) 0.80
High resolution Ca/P maps of bone architecture in 3D synchrotron radiation microtomographic images. Appl Radiat Isot (2005) 0.79
Preliminary estimates of the calcium/phosphorus ratio at different cortical bone sites using synchrotron microCT. Phys Med Biol (2006) 0.78